Partner with a CRO That Can Bring a Unique Advantage to Early Clinical Research

We integrate real-world healthcare experience to deliver an expertise in pharmacology and drug clearance studies, and access to robust datasets and industry leading analytics that could help to further the design and recruitment of complex studies that support regulatory submissions. In addition, our operational excellence, superior customer service, flexibility and quality data makes DaVita Clinical Research (DCR) a leading choice for outsourced Phase I clinical research.

With two hospital-based facilities dedicated to early clinical research, DCR brings a track record of success to your Phase I clinical trials. For more than 30 years, we have helped over 175 biopharmaceutical clients efficiently and effectively manage and execute early clinical research in both healthy normal volunteers and specialty patient populations. Our integrated clinical data analysis and reporting offering allows for effective and timely decisions about safety and efficacy. Find out more about our clinical research expertise.

  • More than 300 early clinical research trials for more than 175 pharmaceutical and biotech companies
  • Leadership with extensive experience in drug development and clinical pharmacology
  • Extensive Phase I trial experience in the last 3 years, including:
    • Studies in healthy normal volunteers and patient populations, including FIH/SAD/MAD studies
    • Cardiovascular studies
    • More than 60 renal and hepatic clearance studies enrolling more than 700 patients
  • Hospital based facilities in Denver and Minneapolis with 122 total beds operating under common SOPs and access to numerous patient populations, physicians and ancillary services reporting

Early Clinical Research Studies for Regulatory Submission

Mass balance (ADME)
Adaptive trial designs
Drug/Drug interaction
Food effect

Specialty Populations

Chronic kidney disease (mild, moderate, severe)
Diabetes (types I and II)
End Stage Renal Disease
Hepatic (mild, moderate, severe)
Cardiovascular NY classification II, III, IV

Special Procedures Available

Actual renal function measurement via Iohexol/PAH
Bio-Z cardiac monitoring
Ophthalmic studies
Full suite of imaging
Pulmonary function
Hypoxia induction
Blood transfusions

Certifications and Licensing

Mortara Certified partner
ACLS Certified nursing and medical staff
USP-797 Certified for high risk compounding
State licensed pharmacy
ISO Class 6 clean room
DEA license for schedule I-IV drugs
APPI Certified physician investigator
Nuclear medicine license


*DaVita Clinical Research® is a subsidiary of DaVita Inc.